2.2(top 20%)
impact factor
13.8K(top 1%)
papers
160.2K(top 5%)
citations
78(top 10%)
h-index
2.3(top 20%)
impact factor
14.5K
all documents
173.7K
doc citations
112(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)Oncology Letters2012679
2Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patientsOncology Letters2012483
3The emerging role of CXCL10 in cancer (Review)Oncology Letters2011322
4Depression in cancer patients: Pathogenesis, implications and treatment (Review)Oncology Letters2015276
5Cancer associated fibroblasts: An essential role in the tumor microenvironmentOncology Letters2017263
6Three‑dimensional cell culture: A powerful tool in tumor research and drug discovery (Review)Oncology Letters2017249
7PKM2 and cancer: The function of PKM2 beyond glycolysisOncology Letters2016243
8Aflatoxin B1-induced hepatocellular carcinoma in developing countries: Geographical distribution, mechanism of action and preventionOncology Letters2013222
9Epithelial-mesenchymal transition in glioblastoma progressionOncology Letters2016207
10Molecular mechanisms of chemoresistance in osteosarcoma (Review)Oncology Letters2014194
11The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCCOncology Letters2016190
12Histological and molecular aspects of oral squamous cell carcinoma (Review)Oncology Letters2014188
13Cervical cancer in low and middle‑income countries (Review)Oncology Letters2020185
14Regulation of let-7 and its target oncogenes (Review)Oncology Letters2012170
15MicroRNAs and cancer: Key paradigms in molecular therapy (Review)Oncology Letters2017168
16Tumor angiogenesis and anti‑angiogenic gene therapy for cancer (Review)Oncology Letters2018160
17Lauren classification and individualized chemotherapy in gastric cancerOncology Letters2016157
18Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinomaOncology Letters2017156
19The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosisOncology Letters2017152
20The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy (Review)Oncology Letters2018147
21Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasmsOncology Letters2014143
22Exosomal microRNA in plasma as a non-invasive biomarker for the recurrence of non-small cell lung cancerOncology Letters2017139
23Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review)Oncology Letters2015128
24Function of PM2.5 in the pathogenesis of lung cancer and chronic airway inflammatory diseases (Review)Oncology Letters2018127
25Progress in the chemotherapeutic treatment of osteosarcoma (Review)Oncology Letters2018126
26Specific organ metastases and survival in small cell lung cancerOncology Letters2012125
27Apigenin suppresses colorectal cancer cell proliferation, migration and invasion via inhibition of the Wnt/β-catenin signaling pathwayOncology Letters2016125
28Immunosuppression of breast cancer cells mediated by transforming growth factor-β in exosomes from cancer cellsOncology Letters2016125
29Voltage-gated calcium channels: Novel targets for cancer therapyOncology Letters2017124
30Differential expression of miRNAs in esophageal cancer tissueOncology Letters2013121
31Antitumor mechanisms of bifidobacteria (Review)Oncology Letters2018120
32A new perspective of vasculogenic mimicry: EMT and cancer stem cells (Review)Oncology Letters2013117
33Molecular and cellular mechanisms of castration resistant prostate cancer (Review)Oncology Letters2018116
34Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasisOncology Letters2015115
35Metformin and cancer: An existing drug for cancer prevention and therapy (Review)Oncology Letters2018115
36Oncology during the COVID‑19 pandemic: challenges, dilemmas and the psychosocial impact on cancer patients (Review)Oncology Letters2020115
37Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patientsOncology Letters2015114
38Anticancer effect of salidroside on A549 lung cancer cells through inhibition of oxidative stress and phospho-p38 expressionOncology Letters2014112
39Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancerOncology Letters2017109
40Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancerOncology Letters2012108
41The role of MALAT1 correlates with HPV in cervical cancerOncology Letters2014108
42Curcumin suppresses colon cancer cell invasion via AMPK-induced inhibition of NF–κB, uPA activator and MMP9Oncology Letters2016108
43Plasma miR-145, miR-20a, miR-21 and miR-223 as novel biomarkers for screening early-stage non-small cell lung cancerOncology Letters2017108
44Fatty acid activation in carcinogenesis and cancer development: Essential roles of long‑chain acyl‑CoA synthetases (Review)Oncology Letters2018105
45BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinomaOncology Letters2014104
46Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancerOncology Letters2015104
47BRAF-activated long non-coding RNA contributes to colorectal cancer migration by inducing epithelial-mesenchymal transitionOncology Letters2014103
48Age is a prognostic factor affecting survival in lung cancer patientsOncology Letters2013102
49Molecular mechanisms of tamoxifen-associated endometrial cancer (Review)Oncology Letters2015102
50Gallic acid reduces cell viability, proliferation, invasion and angiogenesis in human cervical cancer cellsOncology Letters2013101